ATLANTA, March 16, 2026 /PRNewswire/ -- Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer ...

Changes Clinical Practice: Based on this large trial, lithium alone or a lithium-valproate combination should be used as first-line maintenance treatment for bipolar affective disorder type I instead ...

Researchers from the University of Adelaide are hopeful a recent biological discovery could lead to the precision treatment of bipolar disorder (BD). Subscribe to our newsletter for the latest ...

A study this week in the journal Nature found that the loss of lithium, a naturally occurring element in the brain, could be an early sign of Alzheimer’s and a powerful driver of the disease, which ...

Bipolar disorder is a mental health condition estimated to affect between 1% and 3% of people worldwide. Its main symptoms include extreme mood swings, ranging from periods of high activity and ...

Marissa Russo is a former STAT intern supported by the AAAS Mass Media Science & Engineering Fellowship. A new study finds that the element lithium plays a crucial role in healthy brain function and ...

Lithium was associated with a higher risk of thyroid and kidney dysfunction versus non-lithium treatments in bipolar disorder patients. Associations were dose-dependent and serum level cutoffs for ...

Source: Francesco Mocellin / Used with permission Interest in lithium has been renewed in recent years, not only as a classic mood stabilizer for bipolar illness but also as a potential low-dose ...

Low doses in mice have can clear up proteins associated with Alzheimer’s disease and restore memory. Human trials are the next step. Lithium has long been a standard treatment in bipolar disorder, but ...